A consolidation-scope and accounting-treatment topic concerning the change of formerly unconsolidated subsidiaries to equity-method investees due to the increased materiality of net income and other factors. It covers the commencement of equity-method accounting for メディアスソリューション and メディカルバイオサイエンス, and their subsequent status in consolidated accounting.